Skip to main content

Sumavel DosePro FDA Approval History

FDA Approved: Yes (Discontinued) (First approved July 15, 2009)
Brand name: Sumavel DosePro
Generic name: sumatriptan
Dosage form: Injection
Company: Zogenix, Inc.
Treatment for: Migraine, Cluster Headaches

Marketing Status: Discontinued

Sumavel DosePro (sumatriptan injection) is a needle-free delivery system to treat acute migraine (with or without aura), and cluster headache.

Development timeline for Sumavel DosePro

Jul 16, 2009Approval Sumavel DosePro (sumatriptan injection) Approved by FDA for Acute Migraine and Cluster Headache: First Product Featuring Novel DosePro Needle-Free Delivery System
Feb 18, 2009Zogenix Reports FDA Provides New PDUFA Date for Sumavel DosePro

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.